Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Ho Tony W
Executive VP, Head of R&D at CRISPR Therapeutics. Filing since 22 May 2020.
CIK 0001713637
Company
Date
Role
Action
Shares
Amount
Of holding
CRSP
CRISPR Therapeutics AG
21 Dec 2020
Executive VP, Head of R&D
Sold, plan not stated
23,551
$3.51M
40.9%
CRSP
CRISPR Therapeutics AG
23 Jun 2020
Executive VP, Head of R&D
Sold, plan not stated
6,929
$521.06K
17.0%
CRSP
CRISPR Therapeutics AG
22 Jun 2020
Executive VP, Head of R&D
Sold, plan not stated
229
$16.06K
0.6%
CRSP
CRISPR Therapeutics AG
26 May 2020
Executive VP, Head of R&D
Sold, plan not stated
6,100
$427.85K
13.0%
CRSP
CRISPR Therapeutics AG
22 May 2020
Executive VP, Head of R&D
Sold, plan not stated
600
$42.03K
1.3%
5 decisions on file.
